Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istradefylline for Parkinson's Disease Tremor and Motor Symptoms
NCT05885360Phase 4Completed
- Sponsor
- Georgetown University
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Istradefylline in Parkinson's disease (PD), sponsored by Georgetown University. Primary endpoint: MDS-UPDRS Tremor Score at 8 weeks. Started Jan 2023; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT05885360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05885360.